The prevalence, impairment, impact, and burden of premenstrual dysphoric disorder (PMS/PMDD).
about
Selective serotonin reuptake inhibitors for premenstrual syndrome and premenstrual dysphoric disorder: a meta-analysisEffects of sex and gender on adaptation to space: behavioral healthHemodynamic and psychological responses to laboratory stressors in women: assessing the roles of menstrual cycle phase, premenstrual symptomatology, and sleep characteristics.Anxiety sensitivity, the menstrual cycle, and panic disorder: a putative neuroendocrine and psychological interaction.Premenstrual dysphoric disorder: evidence for a new category for DSM-5Lifetime discrimination associated with greater likelihood of premenstrual dysphoric disorderUpdate on research and treatment of premenstrual dysphoric disorder.Ways of coping with premenstrual change: development and validation of a premenstrual coping measureEvaluation of the relative efficacy of a couple cognitive-behaviour therapy (CBT) for Premenstrual Disorders (PMDs), in comparison to one-to-one CBT and a wait list control: A randomized controlled trialTime to relapse after short- or long-term treatment of severe premenstrual syndrome with sertraline.Roles of the µ-opioid receptor and its related signaling pathways in the pathogenesis of premenstrual syndrome liver-qi stagnation.Mental and Reproductive Health Correlates of Academic Performance among Debre Berhan University Female Students, Ethiopia: The Case of Premenstrual Dysphoric DisorderNeurosteroids and GABAergic signaling in health and diseasePremenstrual distress predicts panic-relevant responding to a CO2 challenge among young adult femalesPredictors of premenstrual impairment among women undergoing prospective assessment for premenstrual dysphoric disorder: a cycle-level analysisThe ESC/E(Z) complex, an effector of response to ovarian steroids, manifests an intrinsic difference in cells from women with premenstrual dysphoric disorder.Identifying Chinese herbal medicine for premenstrual syndrome: implications from a nationwide databasePremenstrual symptoms in young adults born preterm at very low birth weight--from the Helsinki Study of Very Low Birth Weight AdultsPremenstrual syndrome prevalence and fluctuation over time: results from a French population-based survey.Estrogen receptor alpha (ESR-1) associations with psychological traits in women with PMDD and controls.Criteria for premenstrual dysphoric disorder: secondary analyses of relevant data setsSafety, efficacy, actions, and patient acceptability of drospirenone/ethinyl estradiol contraceptive pills in the treatment of premenstrual dysphoric disorderThe complexity of premenstrual dysphoric disorder--risk factors in the population of Polish women.Premenstrual syndrome and premenstrual dysphoric disorder in perimenopausal women.Were there evolutionary advantages to premenstrual syndrome?Core symptoms that discriminate premenstrual syndromeAbnormalities of dorsolateral prefrontal function in women with premenstrual dysphoric disorder: a multimodal neuroimaging studyRisk for premenstrual dysphoric disorder is associated with genetic variation in ESR1, the estrogen receptor alpha gene.Neuroimaging evidence of cerebellar involvement in premenstrual dysphoric disorder.Internet-based cognitive behavioural self-help for premenstrual syndrome: study protocol for a randomised controlled trial.Exposure to American culture is associated with premenstrual dysphoric disorder among ethnic minority womenAesthetic and incentive salience of cute infant faces: studies of observer sex, oral contraception and menstrual cycle.Sleep and Women's Health.Prevalence of premenstrual symptoms: Preliminary analysis and brief review of management strategies.Plasma 25-hydroxyvitamin D and risk of premenstrual syndrome in a prospective cohort study.The effect of premenstrual syndrome and menstrual phase on postoperative pain.Relationship of premenstrual syndrome and premenstrual dysphoric disorder with major depression: relevance to clinical practice.Clinical subtypes of premenstrual syndrome and responses to sertraline treatmentPredicting response to leuprolide of women with premenstrual dysphoric disorder by daily mood rating dynamicsYoga Nidra as a complementary treatment of anxiety and depressive symptoms in patients with menstrual disorder
P2860
Q24657580-F7B6DFAE-C15F-4B07-967C-9AEEECD7D1D3Q26824470-0B3349E9-DC1A-4C6F-A959-CBDA7C58EE00Q30383971-955F8BAB-CE78-4082-80B3-C651DD6EEC83Q30461432-C1906AAA-8CB5-48EB-90EC-DFCF495B2451Q30462752-4E3C781C-6578-4A52-B0C9-859C100CE60EQ30467161-E6A274BC-4D6F-432D-A352-4AC6ED09D6EAQ30475462-8D141718-2CCE-4846-87AD-E3BAB56EC069Q30562151-B6D4F5F2-AA75-4453-AE40-0158E7F2F584Q33574386-28739629-6DD4-4106-A60F-E8AE00F8E582Q33697490-DE584529-2C05-49CD-8564-CC4625233848Q33744877-3EF33C03-D49D-4687-8B42-5DB415B1321EQ33786750-8F6E7A74-EAB5-4A32-BF75-6A2D61634016Q33792908-9F24510E-4214-4A82-9B18-04CDE337ABF6Q33833036-901F344B-F90B-4DEB-9030-CAAC60C841BFQ33839337-55BCE8B0-BA97-413A-9012-BA9C7C773B01Q33866563-D84FEFFA-8F2D-4694-9155-4F6B320633E4Q33905918-AFE59AF2-5164-4B09-AFC6-56B89BBEC8CFQ33922368-7E140F9B-85DE-4109-8118-E6D197CE4BA6Q34015402-8D273BB8-935C-4D91-A04A-20BB5B56A3AAQ34170320-DC1B6A8A-9F52-48C1-B36E-3F70B75B3D97Q34185554-3D869D0D-DFD9-45CE-8E2C-1097700AD99BQ34272049-B3ED5D11-150A-42DC-B98F-8E3F7122A83BQ34353821-94B41B17-1D65-49CA-BADC-53D424032210Q34391183-E4511AC7-F4F7-4C5C-BED4-D8737F57221FQ34414749-0FEBEDB5-E520-4189-B1D5-EFF61733BEE5Q34473217-849C6C3A-AE58-43CC-B790-BCE72BD7A69AQ34567209-E86F2670-4CF4-4FD7-9952-32BF01276643Q34643299-71609A98-9328-4D69-ADA9-750A1810335AQ34645878-834CE8AB-4520-4D2D-96B3-3CF3FD6412BBQ34695695-E88B02DD-275D-4419-BF17-F2706D7724C4Q34744601-2D84718F-FBF3-4D21-B7B9-87B69D19612AQ34756081-7C200F30-2C4D-432B-BF64-2CF710C53F3FQ35082978-C3B5AEB7-9F42-436A-9760-B3EEE27472B8Q35114119-F484C8E1-02CC-43DD-9442-D050DE0C49F5Q35146232-223D44A2-5AD1-4117-A2DB-8EC9BDB028C4Q35226009-B869E559-45BD-4BF1-909A-57DDF6BC2928Q35564965-3936B050-A545-47D3-B040-A22E5CB0C0C3Q35569566-E53F98A2-200B-4C88-97DE-BE8B313A35B3Q35683485-97471137-DEB2-4775-BAD2-B7F23996C3C7Q35749146-D4AFB927-4FF1-41CF-99CE-163E185FC30E
P2860
The prevalence, impairment, impact, and burden of premenstrual dysphoric disorder (PMS/PMDD).
description
2003 nî lūn-bûn
@nan
2003 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
The prevalence, impairment, im ...... dysphoric disorder (PMS/PMDD).
@ast
The prevalence, impairment, im ...... dysphoric disorder (PMS/PMDD).
@en
type
label
The prevalence, impairment, im ...... dysphoric disorder (PMS/PMDD).
@ast
The prevalence, impairment, im ...... dysphoric disorder (PMS/PMDD).
@en
prefLabel
The prevalence, impairment, im ...... dysphoric disorder (PMS/PMDD).
@ast
The prevalence, impairment, im ...... dysphoric disorder (PMS/PMDD).
@en
P2093
P1476
The prevalence, impairment, im ...... dysphoric disorder (PMS/PMDD).
@en
P2093
Jeff Borenstein
Linda S Kahn
Terry Pearlstein
Uriel Halbreich
P478
28 Suppl 3
P577
2003-08-01T00:00:00Z